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OBJECTIVE The purpose of this study was to evaluate the value of activation mapping for radiofrequency
modification of the sinus node and the long-term success rate of the procedure in a series of
patients with inappropriate sinus tachycardia.
BACKGROUND The results of radiofrequency ablation of inappropriate sinus tachycardia have been reported
in only a small number of patients.
METHODS The subjects of this study were 29 consecutive drug-refractory patients who underwent
catheter ablation of inappropriate sinus tachycardia. Target sites were selected by activation
mapping during sinus tachycardia.
RESULTS The ablation procedure was successful acutely in reducing the baseline sinus rate to ,90/min
and the sinus rate during isoproterenol infusion by .20% in 22 of 29 patients (76%). In 13
of 22 patients (59%) with a successful acute outcome, successive applications of radiofre-
quency energy at the site of earliest endocardial activation resulted in a cranial-caudal
migration of earliest endocardial activation from the high lateral right atrium, along with a
step-wise reduction in heart rate. In the other nine patients (41%) with a successful acute
outcome, the reduction in sinus rate occurred abruptly, unaccompanied by migration of the
site of earliest activation. Symptoms due to inappropriate sinus tachycardia recurred at a mean
of 4.46; 3 months after the ablation procedure in 6 of 22 patients (27%). After additional
procedures in three patients, symptoms of inappropriate sinus tachycardia ultimately were
successfully eliminated over the long-term in 19 of 29 patients (66%).
CONCLUSIONS In conclusion, radiofrequency ablation is at best only modestly effective for managing patients
with inappropriate sinus tachycardia. The two different responses of heart rate to radiofre-
quency ablation may reflect differences in the number and/or multicentricity of subsidiary sites
of impulse generation within the sinus node and/or atrium in patients with inappropriate
sinus tachycardia. (J Am Coll Cardiol 2000;35:451–7) © 2000 by the American College of
Cardiology
Inappropriate sinus tachycardia is characterized by an ele-
vated resting heart rate and/or an exaggerated increase in
heart rate in response to activity (1). In patients with
inappropriate sinus tachycardia who are refractory to med-
ical treatment, radiofrequency catheter modification of the
sinus node may be effective in lowering the sinus rate.
However, the results of radiofrequency ablation (RFA) of
inappropriate sinus tachycardia have been reported in only a
small number of patients (2–4). The purpose of this study
was to determine the long-term results of radiofrequency
modification of the sinus node guided by activation map-
ping in a series of 29 patients with inappropriate sinus
tachycardia.
METHODS
Patient characteristics. Twenty-nine consecutive patients
referred for catheter ablation of inappropriate sinus tachy-
cardia. Inappropriate sinus tachycardia was defined as a
heart rate .100/min at rest or with minimal exertion, with
P waves during tachycardia that were identical or very
similar to the P waves during sinus rhythm, and with no
other identifiable causes for sinus tachycardia, such as
hyperthyroidism or orthostatic hypotension. Inappropriate
sinus tachycardia was distinguished from paroxysmal atrial
tachycardia by a gradual onset and offset. There were 26
women and 3 men, and their mean age was 37 6 12 years
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(6SD). Each of the patients was functionally limited by
symptoms of palpitations, weakness and lightheadedness.
Twenty-seven patients had no structural heart disease, one
patient had coronary artery disease and one patient had
hypertension with left ventricular (LV) hypertrophy. All
patients had a normal LV ejection fraction. The mean
duration of symptoms attributable to inappropriate sinus
tachycardia was 7.2 6 12.7 years. Treatment with a mean of
4.7 6 2.1 antiarrhythmic drugs had failed to provide
adequate control of symptoms. During outpatient evalua-
tion two or more weeks before the RFA procedure, at which
time all of the patients were being treated with a beta-
adrenergic antagonist, calcium channel blocker or amioda-
rone, the mean heart rate while sitting was 93 6 9/min, the
mean heart rate after walking 50 yards was 123 6 8/min and
the mean heart rate after one minute of stair-stepping on a
single step was 151 6 8/min.
Electrophysiologic testing. After written, informed con-
sent was obtained, patients were brought to the electrophys-
iology laboratory in the fasting state. Treatment with
antiarrhythmic medications was discontinued at least five
half-lives before the procedure, except in two patients in
whom therapy with amiodarone was discontinued two to
four weeks beforehand. Three quadripolar electrode cathe-
ters were inserted into a femoral vein and positioned in the
right atrium, His bundle position and right ventricle. Leads
VI, I, II and III, and the bipolar intracardiac electrograms
filtered at settings of 50 to 500 Hz, were recorded on paper
(Mingograph 7; Siemens-Elema, Solna, Sweden) and
stored on optical disk (Quinton, Seattle, WA). Pacing was
performed with a programmable stimulator (Bloom Asso-
ciates, Ltd., Reading, PA) and no patient was found to have
inducible paroxysmal supraventricular tachycardia.
Activation mapping and ablation. Isoproterenol was in-
fused at a rate of 1 to 2 mg/min to maintain a cycle length
of ,500 ms, except in three patients who had a baseline
sinus cycle length ,500 ms. Point-by-point activation
mapping was performed in each patient. An 8-F quadripolar
electrode catheter that had an interelectrode spacing of
2-5-2 mm, a 4-mm distal electrode with an imbedded
thermistor and a deflectable tip (EP Technologies, Sunny-
vale, California) was used for mapping and ablation. Radio-
frequency energy was delivered at the site of the earliest
bipolar electrogram relative to the surface P wave. When the
P waves were obscured by the preceding T waves, short
bursts of ventricular pacing at a cycle length 10 to 20 ms
shorter than the sinus rate were used to uncover the P waves
upon cessation of pacing.
Radiofrequency energy was delivered at a cycle length of
500 kHz by a generator that automatically adjusted the
output to maintain a preset temperature of 50°C to 60°C at
the electrode-tissue interface (EP Technologies). Because of
injury to the phrenic nerve in one of the early patients in this
series, in subsequent patients, pacing at an output of 10 mA
was performed with the ablation catheter before delivery of
radiofrequency energy, to rule out phrenic nerve stimula-
tion. Applications of radiofrequency energy were up to 60 s
in duration. The end points of the procedure were reduction
of the baseline sinus rate to ,90/min, and a 20% or greater
reduction in the sinus rate during infusion of isoproterenol.
The P waves were examined on a 12-lead electrocardiogram
at baseline, during isoproterenol infusion and after each
application of radiofrequency energy, to look for changes in
configuration.
Follow-up. Continuous electrocardiographic monitoring
was performed on an inpatient basis for 24 h after the
procedure. All of the patients were seen in follow-up at four
to six weeks after the procedure and at subsequent six-
month intervals. At the time of follow-up, the heart rate was
measured while sitting, after walking 50 yards at a usual
pace, and after 1 min of stair-stepping. The patients were
instructed to contact one of the authors in the event of
recurrent symptoms of palpitations. If necessary, patients
were provided with a continuous loop monitor to document
the rhythm at the time of symptoms. A telephone interview
with each patient was performed at the close of the study.
Statistical analysis. Continuous variables are expressed as
mean 6SD and were compared with Student’s t-test or with
a paired t-test. Values of p , 0.05 were considered
statistically significant.
RESULTS
Short-term results. In the electrophysiology laboratory,
the mean baseline sinus cycle length was 623 6 135 msc,
and the mean sinus cycle length during infusion of isopro-
terenol was 413 6 37 msc. The ablation procedure was
successful in reducing the baseline sinus rate to ,90/min
and the sinus rate during isoproterenol infusion by .20%
(mean 26 6 14%) in 22 of 29 patients (76%; Table 1). The
mean number of radiofrequency applications was 22 6 15
(Table 1). The mean duration of fluoroscopy was 59 6
37 min. There were no significant differences in the pre-
ablation baseline sinus cycle length or in the sinus cycle
length during isoproterenol infusion between the patients in
whom the short-term outcome was successful and those in
whom it was not.
Postablation, the baseline sinus cycle length lengthened
significantly to 748 6 118 msc (p , 0.05) among the 22
patients with a successful outcome, and remained un-
changed at 641 6 106 msc (p 5 0.10) among the 7 patients
Abbreviations and Acronyms
LV 5 left ventricular
RA 5 right atrium
RFA 5 radiofrequency ablation
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with an unsuccessful outcome. Likewise, the postablation
sinus cycle length during infusion of isoproterenol length-
ened significantly to 527 6 81 ms (p , 0.01) among the 22
patients with a successful outcome, and remained un-
changed at 436 6 43 msc (p 5 0.08) among the 7 patients
with an unsuccessful outcome.
Activation times (Table 1). The earliest local atrial elec-
trogram in each patient at sites of radiofrequency energy
application preceded the P wave by a mean of 29 6 14 ms.
There was no significant difference in the earliest endocar-
dial activation time between the patients who had a suc-
cessful outcome and those who did not.
In 13 of 22 patients (59%) with a successful acute
outcome, consecutive applications of radiofrequency energy
at the site of earliest endocardial activation resulted in a
cranial-to-caudal migratory pattern of earliest endocardial
activation, starting in the high lateral right atrium (RA) and
descending to the mid-lateral RA over a distance of approx-
imately 2 to 3 cm. In these 13 patients, the reduction in
sinus rate occurred in a step-wise fashion and was associated
with visually apparent changes in P wave morphology
(Fig. 1). A mean of 32.3 6 11 applications of radiofre-
quency energy was required to achieve a successful outcome
in these patients.
In the other nine patients (41%) with a successful acute
outcome, the reduction in sinus rate occurred abruptly and
was not accompanied by migration of the site of earliest
endocardial activation (Fig. 2). The effective target sites
were in the high lateral RA within an area of approximately
1 cm2, and a mean of 7.5 6 5.6 applications of radiofre-
quency energy was required to achieve a successful acute
outcome.
Complications. A complication occurred in 2 of 29 pa-
tients (7%). Patient 4 presented with near-syncope four days
after the procedure and was found to have sinus pauses up to
4 s in duration. A dual-chamber pacemaker was implanted
and the patient was asymptomatic until 10 months after the
procedure, at which point inappropriate sinus tachycardia
recurred. Radiofrequency ablation of the atrioventricular
junction was performed, with resolution of symptoms. One
other patient, who had received 25 applications of radiofre-
quency energy in the high lateral RA, developed paralysis of
Table 1. Results of RFA of Inappropriate Sinus Tachycardia
Patient
Age (years)/
Gender
Act
Time
No. of
Sessions
No. of
RFA
Abrupt HR
Response
Acute
Result
Months
of F/u
Long-Term
Treatment
Long-Term
Sx Relief
1 40/M 249 1 18 No Succ 50 None Yes
2 26/F 240 1 47 No Succ 49 None Yes
3 32/F 225 1 27 No Succ 48 None Yes
4 27/F 250 1 16 No Succ 47 AVN Abl Yes
5 19/M 260 1 36 No Succ 47 None Yes
6 47/M 225 1 51 No Succ 45 None Yes
7 29/F 235 1 6 Yes Succ 44 None Yes
8 49/F 255 1 33 No Fail 43 BB Partial
9 44/F 230 1 7 Yes Succ 42 None Yes
10 34/F 245 1 26 No Succ 41 None Yes
11 29/F 240 1 4 Yes Succ 38 None Yes
12 30/F 230 1 4 Yes Succ 35 BB Partial
13 44/F 240 2 31 No Succ 34 None Yes
14 42/F 230 1 29 No Fail 34 BB Partial
15 25/F 220 1 47 No Fail 32 AVN Abl Partial
16 31/F 220 1 28 No Succ 31 AVN Abl Yes
17 23/F 230 1 20 Yes Succ 29 None Yes
18 27/F 210 1 1 Yes Succ 29 None Yes
19 24/F 225 1 40 No Fail 25 AVN Abl Yes
20 36/F 225 1 25 No Succ 25 None Yes
21 26/F 215 1 43 No Fail 24 BB Partial
22 45/F 220 1 41 No Succ 23 None Yes
23 66/F 230 1 5 Yes Succ 19 None Yes
24 52/F 220 3 57 No Succ 19 None Yes
25 47/F 210 1 21 No Fail 18 BB Partial
26 33/F 210 1 34 No Fail 16 AVN Abl Yes
27 29/F 235 2 36 No Succ 13 None Yes
28 59/F 210 1 5 Yes Succ 12 None Yes
29 44/F 220 1 2 Yes Succ 12 None Yes
Act time 5 earliest endocardial activation time relative to onset of P wave; AVN Abl 5 atrioventricular node ablation/pacemaker; BB 5 beta-blocker; F 5 female; Fail 5 failure;
F/u 5 follow-up; HR 5 heart rate; M 5 male; RFA 5 applications of radiofrequency energy in all sessions; Succ 5 success; Sx 5 symptoms attributable to inappropriate sinus
tachycardia.
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the right hemidiaphragm. The patient has remained asymp-
tomatic during 41 months of follow-up, despite persistence
of diaphragmatic paralysis.
Clinical follow-up (Table 1). After a mean duration of
follow-up of 32 6 12 months (range 12 to 50 months), 16
of the 22 patients (73%) in whom the procedure was acutely
successful either have remained free of recurrent symptoms
in the absence of drug therapy, or have had mild symptoms
not bothersome enough to require drug therapy. At the time
of the most recent outpatient evaluation (12 to 42 months
postprocedure), the heart rates at rest, after walking 50 yards
and after 1 min of stair-stepping were 80 6 8, 93 6 9 and
121 6 9/min, respectively, in these 16 patients. These mean
heart rates were significantly lower than the respective mean
heart rates before the RFA procedure (p , 0.01).
Symptoms documented to be due to inappropriate sinus
tachycardia recurred at a mean of 4.4 6 3 months (range 2
weeks to 8 months) after the ablation procedure in 6 of the
22 patients (27%) in whom the procedure was acutely
successful. A successful long-term outcome was achieved
with an additional procedure in two patients, and with two
additional procedures in one patient. Overall, among the 29
patients in this series, the radiofrequency procedure was
successful in eliminating symptoms of inappropriate sinus
tachycardia requiring drug therapy over the long term in 19
patients (66%).
Among the 10 patients in whom the ablation procedure
was not successful, five patients continued to have severe
symptoms attributable to inappropriate sinus tachycardia
and underwent RFA of the atrioventricular junction and
implantation of a pacemaker; relief of symptoms was com-
plete in four of these patients and partial in one. The other
five patients who had an unsuccessful outcome have had
their symptoms partially controlled by treatment with beta-
blockers.
DISCUSSION
Major findings. In this study, a successful long-term re-
duction in the sinus rate and relief of symptoms without the
use of pharmacologic therapy was achieved by RFA at the
sites of earliest atrial activation in approximately two-thirds
of patients with drug-refractory, inappropriate sinus tachy-
cardia. Two types of responses of the sinus tachycardia to
RFA were observed. In approximately 60% of patients,
there was a step-wise reduction in sinus rate, and this was
Figure 1. An example of a step-wise increase in cycle length in
response to radiofrequency ablation of inappropriate sinus tachy-
cardia (patient 27, second procedure). Shown are leads I, II and III
at several stages of the procedure. (A) The baseline sinus cycle
length (CL) was 600 ms. (B) During infusion of isoproterenol (iso)
at a rate of 1 mg/min, the cycle length shortened to 440 ms, and the
P waves in lead III were larger in amplitude. The isoproterenol
infusion was continued during the radiofrequency procedure. (C)
After several applications of radiofrequency energy at the site of
earliest endocardial activation (235 ms) in the high lateral right
atrium, the cycle length increased to 510 ms, and there was a
change in P wave morphology in all three leads. (D) After
additional applications of radiofrequency energy at a new site of
earliest endocardial activation (225 ms) approximately 2 cm
caudal to the original ablation site, the cycle length increased to
580 ms, again with a change in P wave morphology. The 32%
increase in cycle length during isoproterenol infusion was consid-
ered to be an adequate endpoint for the procedure. (E) After
discontinuation of the isoproterenol infusion, the resting cycle
length was 780 ms, representing a 30% increase compared with the
baseline cycle length. Note that after discontinuation of the
isoproterenol infusion, the P wave morphology again changed.
Figure 2. An example of an abrupt response of inappropriate sinus
tachycardia to radiofrequency ablation (Patient 7). Shown are leads
V1, I and II, an electrogram recorded in the right atrium (RA) near
the ablation site, a recording from the ablation catheter in the high
lateral right atrium (HRA) and lead III. The cycle length during a
2-mg/min infusion of isoproterenol was 400 ms, and the first five
applications of radiofrequency energy at the site of earliest endo-
cardial activation (235 ms) had only either a temporary or no effect
on the cycle length. Approximately 2 s after the onset of the sixth
application of radiofrequency energy (RF), there was an abrupt and
permanent 42% increase in cycle length to 570 ms. In this patient,
the P wave morphology after radiofrequency ablation of the
inappropriate sinus tachycardia did not change.
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associated with migration of the site of earliest atrial
activation in a cranial-caudal direction along the lateral right
atrial wall. In the remaining patients, the heart rate dropped
abruptly in response to RFA at a focal site of earliest atrial
activation. These two different responses of the heart rate to
RFA may reflect differences in the number and/or multi-
centricity of subsidiary sites of impulse generation within
the sinus node and/or atrium in patients with inappropriate
sinus tachycardia.
Activation mapping of inappropriate sinus tachycardia.
The sinus node impulse may have a multifocal origin, and
prior studies have demonstrated that the site of impulse
origin may shift inferiorly within the sinus node and
surrounding atrium as the rate decreases (5–7). This type of
pattern was observed in approximately 60% of the patients
in this study, in whom activation mapping demonstrated a
cranial-caudal migration of the earliest site of endocardial
activation with successive applications of radiofrequency
energy. The inferior shift in the site of earliest endocardial
activation was associated with a step-wise reduction in the
heart rate, consistent with the physiologic behavior of the
sinus node noted in prior studies (5–7). This type of
response also was noted in a recent report of two patients
who underwent modification of the sinus node guided by a
three-dimensional nonfluoroscopic mapping system; with
tridimensional mapping, the earliest site of atrial activation
was demonstrated to shift caudally from the original sinus
node location by 1.8 to 2.3 cm (8).
In the other 40% of patients in this study in whom the
ablation procedure was successful acutely, activation map-
ping demonstrated a clustering of early sites of activation
within a small area in the high lateral RA. In these patients,
the end point of the ablation procedure was achieved
abruptly instead of in a step-wise fashion. This suggests that
in some patients, inappropriate sinus tachycardia is gener-
ated by a single pacemaker site within or adjacent to the
sinus node. It is also possible that there were two or more
pacemaker sites with similar rates in close proximity to each
other in these patients.
The sinus node is a complex structure that is at least
partially insulated from the surrounding atrial myocardium,
and the exit site of an impulse from the sinus node may not
coincide with the site of impulse origin (9). A failure of the
exit site from the sinus node to coincide spatially with the
site of impulse origin may in part explain the large number
of applications of radiofrequency energy needed to achieve a
successful outcome in the patients in this study. It may be
that successive applications of radiofrequency energy re-
sulted in small shifts in the exit site, until the exit site was
close enough to the site of impulse origin to allow its
destruction, or until complete exit block was achieved. In
the patients in whom the procedure was ineffective, it is
possible that the exit sites identified by activation mapping
never were close enough to the sites of impulse origin to
allow for their destruction.
Another limitation of activation mapping in patients with
inappropriate sinus tachycardia is that adjacent sites may
have very similar endocardial activation times, and it may be
difficult to precisely identify the site of earliest endocardial
activation. This limitation of activation mapping also has
been noted when mapping other tachycardias that may be
automatic in nature, such as idiopathic ventricular tachycar-
dia arising in the right ventricular outflow tract (10,11). In
the case of idiopathic ventricular tachycardia arising in the
right ventricular outflow tract, pace mapping has proven to
be an effective alternative for identifying effective target sites
for ablation (10,11). However, because P wave morphology
is not sensitive to changes in the site of impulse origin of up
to 3 cm, pace mapping is not a viable technique for
identifying target sites for ablation in the atrium (12).
Comparison with previous studies. In the only other
published series of patients who underwent radiofrequency
catheter ablation of inappropriate sinus tachycardia, Lee et
al. (4) reported a successful long-term outcome in 83% of 12
patients who underwent radiofrequency modification of the
sinus node. Although this success rate appears to be higher
than the 66% long-term success rate achieved among the 29
patients in the present study, the apparently higher success
rate may be attributable to a smaller sample size in the prior
study. In fact, in a more recent preliminary report from the
same laboratory, long-term follow-up over a mean of 8 6 5
months demonstrated a recurrence rate of 77% among an
expanded group of 22 patients who underwent radiofre-
quency modification of the sinus node using the same
techniques as in the original report (13).
While target sites were identified by activation mapping
in all of the patients in the present study, Lee et al. (4) used
intracardiac echocardiography to identify target sites on the
crista terminalis in more than 50% of their patients. This
methodological difference may provide an explanation for
the 77% recurrence rate of inappropriate sinus tachycardia in
the preliminary report from the same laboratory (13),
compared with the 27% recurrence rate in the present study.
Because subsidiary atrial pacemakers that lie outside the
sinus node may play a role in generating inappropriate sinus
tachycardia, an anatomic approach to modification of the
sinus node using intracardiac echocardiography to identify
sites on the crista terminalis may not be as reliable as
activation mapping, in which target sites are not necessarily
restricted to the crista terminalis or sinus node.
Complications. One of the complications encountered in
this study was paralysis of the right hemidiaphragm, pre-
sumably caused by thermal injury to the right phrenic nerve,
which lies on the outside of the RA. The occurrence of this
complication indicates that the lesion created in the RA
with a conventional ablation catheter is at least sometimes
transmural. After encountering this complication in one of
the early patients in this series, additional instances of
hemidiaphragmatic paralysis were avoided by high-output
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pacing at potential target sites, to rule out phrenic nerve
stimulation.
The other complication in this study was symptomatic
junctional bradycardia, reflecting excessive injury to the
sinus node and an absence of an atrial escape rhythm. This
complication was not manifest until four days after the
ablation procedure, indicating that injury to the sinus node
may be progressive after the procedure has been completed.
Also of note is that the delayed onset of symptomatic
bradycardia in the patient who had this complication could
not have been predicted from events during the ablation
procedure. Therefore, it is likely that the occasional need for
a permanent pacemaker after radiofrequency modification
of the sinus node will not be avoidable.
Study limitations. The precise anatomic location of each
application of radiofrequency energy could not be deter-
mined. The sinus node lies beneath the crista terminalis
(14), which can be visualized by intracardiac echocardiog-
raphy (4). Because mapping in this study was based on
analysis of local electrograms and was guided by fluoroscopy
but not intracardiac echocardiography, whether the effective
target sites were limited to the crista terminalis or also
encompassed other sites is unknown. Therefore, this study
does not clarify the extent to which extranodal pacemakers
contribute to the syndrome of inappropriate sinus tachycar-
dia.
Another limitation of this study is the absence of well-
defined criteria for assessing the short- and long-term
outcomes of the radiofrequency procedure. The criteria used
to define acute efficacy in this study (resting heart rate
,90/min and a .20% reduction in heart rate during
infusion of isoproterenol) were chosen arbitrarily, did not
take into account the presence or absence of symptoms and
were not prevalidated. However, when these criteria were
met in the electrophysiology laboratory, the need for long-
term drug therapy usually was eliminated, suggesting that
these criteria, albeit arbitrary, were reasonable.
During the ablation procedures, isoproterenol was in-
fused at a rate of 1 to 2 mg/min, resulting in a mean heart
rate of approximately 150/min during mapping. It is possi-
ble that the use of a higher dosage of isoproterenol would
have affected the results of mapping.
Regarding the assessment of long-term efficacy, this was
based on relief of symptoms, which may be subjective and
patient specific. For example, despite a similar heart rate
during effort, a given patient may describe symptoms as
being absent or minimal, while another patient may expe-
rience symptoms severe enough to warrant drug therapy.
Furthermore, in contrast to other arrhythmias such as
atrioventricular nodal reentrant tachycardia or atrial flutter,
sinus tachycardia is a continuum, without a well-defined
boundary between “inappropriate” and “physiologic.” A
formal assessment of the impact of the ablation procedure
on quality of life was not performed in this study.
CONCLUSIONS
Radiofrequency ablation is at best only a modestly effective
technique for managing patients with inappropriate sinus
tachycardia. Compared with RFA of accessory pathways
(15), atrioventricular nodal reentrant tachycardia (15) atrial
flutter (15) or the atrioventricular junction (16), RFA of
inappropriate sinus tachycardia requires a large number of
applications of radiofrequency energy, has a low success rate
and is associated with a high recurrence rate. These limita-
tions of the procedure may be attributable to the complex
physiology of the sinus node, the inability to precisely target
sites of impulse origin, the large size of the sinus node
relative to the size of the lesion created by conventional
RFA and/or to the possible contribution of shifting, extra-
nodal pacemaker sites to generation of inappropriate sinus
tachycardia. It is possible that larger lesions, such as those
created with a saline-cooled ablation catheter (17), will
improve the success rate, but larger lesions also may result in
a higher rate of complications, including the need for a
permanent pacemaker.
Because of the suboptimal results of RFA of inappropri-
ate sinus tachycardia, this procedure should be considered
only in drug-refractory patients who have severe symptoms.
If a successful outcome cannot be achieved with this
technique, RFA of the atrioventricular junction and implan-
tation of a pacemaker may provide an effective alternative.
In the present study, symptoms usually were relieved after
atrioventricular junction ablation in association with either
dual-chamber pacing and an upper rate limit of 120/min, or
rate-responsive ventricular pacing. Given the technical ease
and reliable long-term success of atrioventricular junction
ablation (16), further studies to compare outcomes of
radiofrequency modification of the sinus node and radiofre-
quency ablation of the atrioventricular junction in patients
with inappropriate sinus tachycardia may be justified.
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